Professor Long leads an extensive clinical trials team and laboratory
at MIA, with a focus on targeted therapies and immuno-oncology in
melanoma. She is principal investigator on Phase I, II and III clinical
trials in adjuvant and metastatic
melanoma, including trials in patients with active brain metastases.
She is the chief investigator on NHMRC-funded research into the
molecular biology of melanoma, with a particular interest in clinical
and tissue biomarker correlates of systemic therapy sensitivity and resistance.
In recognition of her ground-breaking research, Professor Long has
received a number of awards, including the prestigious Sir Zelman Cowen
Universities Fund Prize for Discovery in Medical Research in 2016, and a
number of recent CINSW Premier’s Awards for Outstanding Cancer
Research: In 2014, she was awarded the Wildfire Award for the most
highly-cited, original, peer-reviewed article published in 2011; and in
2013 she was named the Outstanding Cancer Research Fellow.
Professor Long is the author of over 135 peer-reviewed publications
in clinical and translational research in melanoma since 2011, including
the New England Journal of Medicine, Lancet, Lancet Oncology, Journal of Clinical Oncology and Cancer Discovery.
Professor Long has presented her work at international conferences and
meetings on more than 120 occasions. She is President-elect for the
prestigious international Society for Melanoma Research (President from
2018), is Chair of the ASCO Scientific Committee for melanoma and skin
cancer, is medical oncology lead for the Australian Melanoma Management
Guidelines Committee, is on the editorial boards of several high-impact
journals, and is a member of the Melanoma Expert Panel for AJCC Cancer Staging System 8th edition.
Professor Long was awarded the University Medal in Organic Chemistry.
She subsequently completed her PhD in Chemistry in the field of
anti-cancer agents and their binding to DNA. She then moved to the USA
to take up a Fulbright Postdoctoral Fellowship at Scripps Research
Institute, exploring nanotechnology in cancer treatment, before
returning to Australia to complete her MBBS (Hons). Professor Long
became a Fellow of the Australasian College of Physicians in January
2008, specialising in medical oncology.
Professor Georgina Long is Conjoint Medical Director of Melanoma
Institute Australia (MIA), and Chair of Melanoma Medical Oncology
and Translational Research at MIA and Royal North Shore Hospital, The University of Sydney.